Bild
Titelmotiv
Eigentümer
RPTU

Focusing on the great mysteries and wonders of life

Why do we age? How do gene scissors contribute to medical progress? What fascinating creatures inhabit the dark depths of the ocean? The Department of Biology at RPTU in Kaiserslautern is highlighting the latest research on these and other topics as part of the “LIFEum3” lecture series. Through December, there will be a monthly lecture held on the second or third Saturday at 3 p.m. at 42kaiserslautern (Eisenbahnstraße 42). Following the lectures, attendees will have the opportunity to speak with the researchers in person. Admission is free.

To kick off the series on February 14, Professor Johannes Herrmann will take all interested participants on a journey into the field of gerontology. He will explain why human lifespan is limited, where our biological clock is located, and how this timer works. After all, human aging cannot be compared to the wear and tear of a car battery or a rain jacket. Our nerve cells live as long as we do; they can easily reach 90 years of age and still function perfectly. Our cells and tissues regenerate and repair potential damage very reliably. In this context, Herrmann also addresses “healthy aging”—that is, the question of how one can live a healthy and active life without limitations despite advancing age.

On March 14, Professor Stefanie Müller-Schüssele will explain what makes mitochondria and chloroplasts so special. She will provide insights into the evolutionary development of these cell organelles, which enable metabolic processes such as photosynthesis and respiration.

On April 11, Professor Tanja Maritzen will discuss how the genetic material in our cells can be specifically modified. The focus will be on the so-called CRISPR/Cas method—a genetic scissors—and the new possibilities its application opens up in medicine.

On May 16, Professor Stefan Kins will provide an overview of the current state of Alzheimer’s research. He will explain the biological mechanisms underlying the disease’s development as well as known risk factors for this neurodegenerative disorder. In addition, he will highlight current drug treatment approaches along with their potential and limitations.

A complete overview of the dates and a brief description of the topics are available on the event website.

54